<DOC>
	<DOCNO>NCT00835068</DOCNO>
	<brief_summary>The primary objective observational study collect safety data reformulate BeneFIX prescribe routine clinical practice condition France . The secondary objective collect data clinical course individual treat reformulate BeneFIX ease reformulate BeneFIX .</brief_summary>
	<brief_title>Post Marketing Observational Study Reformulated BeneFIX</brief_title>
	<detailed_description>No sampling</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<criteria>Subjects Hemophilia B already receive start treatment reformulate BeneFIX . Subjects date sign informed consent form . Ongoing treatment Hemophilia B product reformulate BeneFIX . Participation European prospective registry patient Hemophilia B treat BeneFIX ( Wyeth protocol 3090A101039 ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Hemophilia B</keyword>
	<keyword>observational</keyword>
	<keyword>post marketing study</keyword>
</DOC>